12.96
前日終値:
$12.63
開ける:
$12.64
24時間の取引高:
1.44M
Relative Volume:
1.11
時価総額:
$1.01B
収益:
$1.53B
当期純損益:
$40.23M
株価収益率:
25.92
EPS:
0.5
ネットキャッシュフロー:
$60.93M
1週間 パフォーマンス:
+5.28%
1か月 パフォーマンス:
-0.31%
6か月 パフォーマンス:
-48.61%
1年 パフォーマンス:
-40.50%
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
名前
Integra Lifesciences Holdings Corp
セクター
電話
(609) 275-0500
住所
1100 CAMPUS ROAD, PRINCETON, NJ
IART を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
IART
Integra Lifesciences Holdings Corp
|
12.96 | 963.76M | 1.53B | 40.23M | 60.93M | 0.50 |
![]()
ABT
Abbott Laboratories
|
134.28 | 227.88B | 43.11B | 13.98B | 6.78B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
103.14 | 152.55B | 18.49B | 2.51B | 3.23B | 1.68 |
![]()
SYK
Stryker Corp
|
377.58 | 143.34B | 23.82B | 2.92B | 4.02B | 7.55 |
![]()
MDT
Medtronic Plc
|
92.88 | 114.49B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
78.35 | 46.11B | 5.69B | 4.14B | 577.90M | 6.96 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-03-31 | アップグレード | Argus | Hold → Buy |
2024-12-02 | 開始されました | Morgan Stanley | Underweight |
2024-10-07 | アップグレード | BTIG Research | Sell → Neutral |
2024-07-30 | ダウングレード | BTIG Research | Neutral → Sell |
2024-07-30 | ダウングレード | Citigroup | Neutral → Sell |
2024-05-07 | ダウングレード | Oppenheimer | Outperform → Perform |
2024-05-07 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
2024-04-03 | アップグレード | Citigroup | Sell → Neutral |
2023-12-05 | アップグレード | Wells Fargo | Equal Weight → Overweight |
2023-11-14 | 開始されました | CL King | Buy |
2023-08-24 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
2023-07-12 | アップグレード | Jefferies | Hold → Buy |
2023-06-08 | ダウングレード | Argus | Buy → Hold |
2023-05-24 | ダウングレード | JP Morgan | Neutral → Underweight |
2023-05-23 | ダウングレード | Citigroup | Neutral → Sell |
2022-10-12 | 開始されました | Jefferies | Hold |
2022-07-25 | 開始されました | Morgan Stanley | Equal-Weight |
2022-04-13 | ダウングレード | Truist | Buy → Hold |
2021-12-17 | アップグレード | JP Morgan | Underweight → Neutral |
2021-09-15 | ダウングレード | BTIG Research | Buy → Neutral |
2020-10-08 | ダウングレード | JP Morgan | Neutral → Underweight |
2020-05-27 | 開始されました | Citigroup | Neutral |
2020-04-03 | 開始されました | SunTrust | Buy |
2020-01-07 | ダウングレード | Piper Jaffray | Overweight → Neutral |
2020-01-07 | ダウングレード | Piper Sandler | Overweight → Neutral |
2019-01-03 | 開始されました | SunTrust | Buy |
2018-11-28 | 開始されました | UBS | Neutral |
2018-08-07 | ダウングレード | BofA/Merrill | Neutral → Underperform |
2018-07-26 | アップグレード | BTIG Research | Neutral → Buy |
2018-07-02 | ダウングレード | Citigroup | Buy → Neutral |
2018-01-05 | 再開されました | Cantor Fitzgerald | Neutral |
2018-01-02 | ダウングレード | BofA/Merrill | Buy → Neutral |
2017-11-09 | 繰り返されました | RBC Capital Mkts | Sector Perform |
2017-10-30 | ダウングレード | Wells Fargo | Outperform → Market Perform |
2017-10-27 | ダウングレード | JP Morgan | Overweight → Neutral |
2017-06-30 | 開始されました | Cantor Fitzgerald | Overweight |
2017-05-02 | 繰り返されました | RBC Capital Mkts | Sector Perform |
2017-01-13 | 繰り返されました | RBC Capital Mkts | Sector Perform |
2017-01-06 | アップグレード | JMP Securities | Mkt Perform → Mkt Outperform |
2016-12-12 | 開始されました | UBS | Buy |
すべてを表示
Integra Lifesciences Holdings Corp (IART) 最新ニュース
Top chart patterns to watch in Integra LifeSciences Holdings CorporationBreakout Stock Opportunities with Low Drawdown - Newser
Is now a turning point for Integra LifeSciences Holdings CorporationFree Multi-Bagger Potential Stock Forecast Tools - Newser
Published on: 2025-08-10 02:52:05 - Newser
What’s the recovery path for long term holders of Integra LifeSciences Holdings CorporationShort-Term AI-Based Stock Price Forecast - Newser
Using data models to predict Integra LifeSciences Holdings Corporation stock movementFree Price Action Based Buy Opportunity List - Newser
Price action breakdown for Integra LifeSciences Holdings CorporationStock Market Trend and Pattern Analysis - Newser
Why Integra LifeSciences Holdings Corporation stock attracts strong analyst attentionEntry Optimization Guide with Volume Analysis - Newser
Integra LifeSciences Holdings Corporation’s volatility index tracking explainedLong-Term Allocation Strategy Summary Breakdown - Newser
Technical analysis overview for Integra LifeSciences Holdings Corporation stockSmart Entry Signals for Active Traders - Newser
What makes Integra LifeSciences Holdings Corporation stock price move sharplyBreakout Stock Opportunities with Low Drawdown - Newser
Evaluating Integra LifeSciences Holdings Corporation with trendline analysisTriple Digit Gain Opportunity Watchlist - newser.com
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q2 2025 Earnings Call Transcript - Insider Monkey
Has Integra LifeSciences Holdings Corporation Stock Ever Crashed Historical Volatility ReviewFree Intraday Trend Analysis for Fast Gains - Newser
Integra LifeSciences Holdings Corporation Company’s Quarterly Earnings Growth: What the Numbers SayFree Swing Trading Plan With Smart Signals - Newser
JMP reiterates Market Outperform rating on Integra LifeSciences stock By Investing.com - Investing.com Canada
JMP reiterates Market Outperform rating on Integra LifeSciences stock - Investing.com
KLP Kapitalforvaltning AS Cuts Stake in Integra LifeSciences Holdings Corporation (NASDAQ:IART) - Defense World
How Integra LifeSciences Holdings Corporation stock performs during market volatilityBuy and Hold Return Summary with Charts - Newser
Integra: Q2 Earnings Snapshot - Norwalk Hour
Earnings call transcript: Integra LifeSciences Q2 2025 beats EPS expectations By Investing.com - Investing.com Canada
Earnings call transcript: Integra LifeSciences Q2 2025 beats EPS expectations - Investing.com
Integra Lifesciences Holdings Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Integra LifeSciences Q2 2025 slides: Revenue dips, projects second-half rebound - Investing.com Canada
Integra LifeSciences (IART) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
Integra Lifesciences Holdings Corp Reports Q2 Revenue of $415.6M - GuruFocus
Integra LifeSciences (IART) Reports Strong Q2 Revenue Performanc - GuruFocus
Integra Lifesciences Holdings Corp Reports Q2 Revenue of $415.6M, Exceeding Estimates; Adjusted EPS at $0.45, Surpassing Expectations - GuruFocus
Integra LifeSciences (NASDAQ:IART) Beats Q2 Sales Targets - Yahoo Finance
Integra Lifesciences Topped Revenue Estimates Despite Investor Caution - Finimize
Integra LifeSciences Reports Second Quarter 2025 Financial Results - TradingView
Integra LifeSciences (IART) Reports Strong Q2 Revenue Performance - GuruFocus
Integra Lifesciences Holdings Corp to Report Q2 2025 Earnings on July 31, 2025 with Expected Revenue of $395.07 Million and Earnings of $0.00 per Share - AInvest
Earnings To Watch: Integra Lifesciences Holdings Corp (IART) Reports Q2 2025 Result - Yahoo Finance
Allianz Asset Management GmbH Buys 71,939 Shares of Integra LifeSciences Holdings Corporation (NASDAQ:IART) - Defense World
Integra LifeSciences (IART) Reports Q2: Everything You Need To Know Ahead Of Earnings - Yahoo.co
Published on: 2025-07-29 18:17:19 - metal.it
Cwm LLC Boosts Position in Integra LifeSciences Holdings Corporation (NASDAQ:IART) - Defense World
Published on: 2025-07-28 21:45:23 - metal.it
Should I hold or sell Integra LifeSciences Holdings Corporation stock in 2025Discover breakthrough investment opportunities - Jammu Links News
What is Integra LifeSciences Holdings Corporation company’s growth strategyGet alerts on the hottest stocks daily - jammulinksnews.com
How Efficient Is Integra LifeSciences Holdings Corporation at Controlling Operating CostsFast Growing Stocks - Newser
Integra LifeSciences Holdings Corporation Company Revenue and Profit Trends: A Deep Dive - Newser
Strong week for Integra LifeSciences Holdings (NASDAQ:IART) shareholders doesn't alleviate pain of three-year loss - Yahoo Finance
Can Integra LifeSciences Holdings Corporation stock recover from recent declineOutperformance with explosive growth - Jammu Links News
U.S. Acute External Ventricular Drain Market Analysis Report 2025-2030 Featuring Medtronic, Integra, LifeSciences, Anuncia Medical, Natus, Fuji Systems, B Braun/Aesculap, Boston Scientific, Abbott - uk.finance.yahoo.com
What analysts say about Integra LifeSciences Holdings Corporation stockConsistently exceptional gains - Autocar Professional
What drives Integra LifeSciences Holdings Corporation stock priceUnprecedented profits - Jammu Links News
Bank of New York Mellon Corp Trims Holdings in Integra LifeSciences Holdings Corporation (NASDAQ:IART) - Defense World
Integra Lifesciences Holdings Corp (IART) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):